Fatigue Reduction in Chronic Kidney Disease (CKD)

NYU Langone Health

Status: Completed

Conditions: Chronic Kidney Diseases; Fatigue

Treatments: Behavioral: Cognitive Behavioral Therapy (CBT)

Study type: Interventional

Funder types: Other

Identifiers

NCT06768983

24-01055

Details and patient eligibility

About

In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.

Enrollment: 5 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Interest in participating in a fatigue study
• Age ≥18 years old
• Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2
• Ability and willingness to provide informed consent
• Ability to speak English
• Ability to walk
• Ability to join remote study sessions via WebEx

Exclusion criteria

• Current involvement in an activity/exercise program
• High likelihood of a kidney transplant within 6 months (assessed via the medical record)
• Any safety concerns about increased walking (assessed via the medical record)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

5 participants in 1 patient group

Remotely Delivered Cognitive Behavioral Therapy (CBT)

Experimental group

Description:

Patients with non-dialysis dependent kidney disease who have complaints of fatigue will be enrolled. Participants will receive remotely delivered CBT sessions, which will weekly with the goal of having 10 45-minute sessions over 12 weeks.

Treatment:

Behavioral: Cognitive Behavioral Therapy (CBT)